LAGHI PASINI, FRANCO
 Distribuzione geografica
Continente #
NA - Nord America 12.746
EU - Europa 9.961
AS - Asia 4.630
SA - Sud America 869
AF - Africa 122
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 28.359
Nazione #
US - Stati Uniti d'America 12.621
GB - Regno Unito 2.461
RU - Federazione Russa 1.957
CN - Cina 1.935
SG - Singapore 1.416
IE - Irlanda 1.385
SE - Svezia 842
UA - Ucraina 818
BR - Brasile 750
IT - Italia 749
DE - Germania 728
FR - Francia 441
HK - Hong Kong 369
FI - Finlandia 275
VN - Vietnam 252
KR - Corea 235
IN - India 111
CA - Canada 80
ES - Italia 65
TR - Turchia 60
NL - Olanda 47
BE - Belgio 38
PL - Polonia 37
AR - Argentina 36
CI - Costa d'Avorio 35
JP - Giappone 34
BD - Bangladesh 29
MX - Messico 27
EC - Ecuador 26
IQ - Iraq 24
ZA - Sudafrica 24
CZ - Repubblica Ceca 23
PK - Pakistan 23
AT - Austria 21
MA - Marocco 20
TH - Thailandia 20
VE - Venezuela 16
AU - Australia 13
LT - Lituania 13
UZ - Uzbekistan 13
GR - Grecia 12
EU - Europa 11
KZ - Kazakistan 11
SA - Arabia Saudita 11
IL - Israele 10
AZ - Azerbaigian 9
CO - Colombia 9
DZ - Algeria 8
EG - Egitto 8
ID - Indonesia 8
IR - Iran 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
KE - Kenya 7
TN - Tunisia 7
BG - Bulgaria 6
BO - Bolivia 6
CL - Cile 6
LV - Lettonia 6
NP - Nepal 6
PE - Perù 6
ET - Etiopia 5
HR - Croazia 5
JM - Giamaica 5
MY - Malesia 5
PY - Paraguay 5
RO - Romania 5
UY - Uruguay 5
NZ - Nuova Zelanda 4
OM - Oman 4
RS - Serbia 4
AL - Albania 3
BB - Barbados 3
CY - Cipro 3
KG - Kirghizistan 3
NG - Nigeria 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
GY - Guiana 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CH - Svizzera 1
FK - Isole Falkland (Malvinas) 1
GF - Guiana Francese 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HN - Honduras 1
HU - Ungheria 1
Totale 28.340
Città #
Southend 2.233
Fairfield 1.488
Dallas 1.413
Dublin 1.356
Ashburn 1.030
Singapore 799
Chandler 734
Woodbridge 691
Jacksonville 643
Wilmington 574
Santa Clara 562
Moscow 546
Menlo Park 539
Seattle 537
Houston 533
Beijing 522
Cambridge 470
Ann Arbor 397
Hong Kong 366
Siena 316
Princeton 266
Nanjing 232
Seoul 232
Hefei 231
New York 163
Los Angeles 130
Boardman 118
Dearborn 113
Dong Ket 111
Munich 110
Helsinki 106
The Dalles 103
San Diego 96
San Mateo 92
Buffalo 90
Nanchang 85
São Paulo 63
Shanghai 61
Shenyang 60
Council Bluffs 57
Ho Chi Minh City 52
Florence 46
Málaga 46
Columbus 45
Tianjin 44
Düsseldorf 40
Hebei 40
Turku 39
Venezia 39
Brussels 38
Kunming 37
Milan 37
Abidjan 35
San Francisco 35
Changsha 33
Redondo Beach 33
Jiaxing 32
Hanoi 31
Brooklyn 29
Lancaster 29
London 29
Warsaw 29
Jinan 28
Chicago 27
Guangzhou 26
Izmir 26
Tokyo 26
Bengaluru 25
Montreal 25
Toronto 25
Norwalk 24
Rio de Janeiro 22
Falls Church 21
Zhengzhou 21
Ankara 20
Orem 20
Phoenix 20
Poggiomarino 20
Belo Horizonte 19
Washington 19
Johannesburg 18
Lappeenranta 18
Atlanta 17
Denver 17
Rome 17
Boston 16
Mestre 16
Nuremberg 16
Redwood City 16
Chennai 15
Ningbo 15
Amsterdam 14
Poplar 14
Frankfurt am Main 13
Hangzhou 13
Pune 13
Almere Stad 12
Mumbai 12
Stockholm 12
Tashkent 12
Totale 19.796
Nome #
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 372
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 369
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 369
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 363
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 332
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 326
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 317
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 311
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 299
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 298
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 289
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 288
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 282
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 280
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 275
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 271
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 266
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 266
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 261
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 258
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 255
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 239
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 239
Torsades de Pointes in patients with polymyalgia rheumatica 237
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats 235
QTc interval prolongation during infusion with dipyridamole or adenosine 233
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 229
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. 224
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 224
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 224
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study 223
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 223
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 223
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 223
The role of P2X7 receptors in tissue fibrosis: a brief review 222
Heart failure and chronic kidney disease in a registry of internal medicine wards 221
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 220
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 218
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 218
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 216
Statins and the joint: multiple targets for a global protection? 214
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 213
Cytokine production from peripheral mononuclear cells in 2 patients affected by adrenomyeloneuropathy 212
Human rheumatoid synoviocytes express functional P2X7 receptors 208
Connective tissue diseases and cardiac rhythm disorders: an overview 208
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 208
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 207
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 206
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 205
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 205
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 204
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 204
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation. 199
Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus 198
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 198
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 198
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives 197
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases. 197
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 197
Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series 196
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 192
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 192
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 190
Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids 190
Modulation of P2X7 receptor during inflammation in multiple sclerosis 190
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 187
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 187
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 186
Pathogenesis of the novel autoimmune-associated long-QT syndrome 181
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 181
Evidence of an adenosine-dependent mechanism in the hypotensive effect of L-arginine in man 180
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure 180
Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates 179
Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease 179
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 177
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 176
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 174
Familial Mediterranean fever diagnosed in an elderly patient 173
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 173
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature 172
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 171
Haemodynamics, rheology and mechanism of action of iloprost in man 170
Diurnal rhythm of the anticoagulant effect of continuous i.v. infusion of unfractioned heparin: a possible role for platelet activation 169
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 169
Peripheral neuropathy associated with ischemic vascular disease of the lower limbs 166
Variazioni diurne dell’ effetto anticoagulante dell’ eparina non frazionata in corso di infusione continua e.v. nell’ uomo. Modificazioni indotte da acido acetlsalicico per os 165
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 164
ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family 163
Effect ofthymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study. arthritis patients. -I) In vitro study 163
Enhanced apoptosis of peripheral blood mononuclear cells (PBMC) in cardiac transplanted patients undergoing chronic immunosuppressive treatment 163
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 162
Photopheresis immunomodulation after heart transplantation. 162
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 162
Homocysteine and Raynaud’s phenomenon: a review 162
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 159
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 158
Effects ofthymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoidarthritis patients.-II) In vivo study 158
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 158
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 157
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 155
Totale 21.607
Categoria #
all - tutte 87.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.855 0 0 0 0 0 348 111 375 287 262 230 242
2021/20222.075 147 273 129 173 135 58 103 105 113 180 206 453
2022/20232.706 168 243 394 385 245 546 70 191 289 64 61 50
2023/20242.205 98 31 168 103 103 632 720 57 22 51 55 165
2024/20253.944 74 207 350 248 514 238 131 216 317 175 449 1.025
2025/20266.255 763 1.369 940 1.063 1.890 230 0 0 0 0 0 0
Totale 28.634